VIP
Limited evidence — Early or sparse dataWhat it is
Vasoactive intestinal peptide, a signalling hormone studied for inflammation and (intranasally) for CIRS-type protocols.
VIP (vasoactive intestinal peptide) is a signalling hormone studied for inflammation and, intranasally, in CIRS-type protocols. It can lower blood pressure.
Research context
Studied in relation to:
- Anti-inflammatory/immune research
Points in its favour in the literature:
- Genuine physiological signalling role
Caveats and unknowns:
- Human therapeutic evidence limited
- Can affect blood pressure
- Unlicensed as therapy
Handling & reference data
Route in published researchIntranasal (common) or subcutaneous.
Published clinical / research context (not instructions)Intranasal research protocols ~50 mcg per spray, several times daily.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | VP5 |
| 10mg | VP10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.